|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 38/15 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 2802340 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13701320.7 |
| Europos patento paraiškos padavimo data | 2013-01-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/021212 |
| Data | 2013-01-11 |
| (87) | Numeris | WO 2013/106696 |
| Data | 2013-07-18 |
| (30) | Numeris | Data | Šalis |
| 201261586066 P | 2012-01-12 | US |
| (72) |
HUANG, Lianfeng, US
HUI, Ho-wah, US
PEYKOV, Victor, US
FOSS, Willard, R., US
NARINGREKAR, Vijay, US
LAI, Mei, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | ROMIDEPSIN FORMULATIONS AND USES THEREOF |
| ROMIDEPSIN FORMULATIONS AND USES THEREOF |